60 Minutes profiles Partners in Health co-founder Paul Farmer

NewsGuard 100/100 Score

CBS' "60 Minutes" on Sunday profiled Paul Farmer, co-founder of Partners in Health, which provides no-cost medical care for people with HIV/AIDS, tuberculosis, malaria and other conditions in Haiti and eight other countries worldwide.

The group's work focuses on increasing access to medical care by lowering treatment costs and training local residents to provide care.

Jim Kim, professor at Harvard Medical School and a co-founder of Partners in Health, said that when Farmer "stared treating people in 1998 in Haiti, everyone said he was absolutely nuts," adding, "And here we are, you know, not even a decade later, where the goal is to treat every single human on the planet who needs HIV treatment with the right drugs."

According to "60 Minutes," Kim and Farmer also have worked to lower prices for drugs to treat multi-drug resistant TB by improving access to generics. In addition, the organization trains community health workers to visit HIV/AIDS and TB patients at home to ensure they adhere to their treatment regimens (Pitts, "60 Minutes," CBS, 5/4).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show